Brainstorm Cell Therapeutics Inc
Contact Information
Company Details
Location Type: Headquarters
Industry: Biological Products, Except Diagnostic Substances
Ownership: Public
Year Founded: 2000
Sales Range: $500,000 to $999,999
Employees: 20 to 50
Is This Your Customer, Supplier, Or Partner?
Is This Your Business?
Is This Your Customer, Supplier, Or Partner?
Pull Their Credit Report CREATE A FREE ACCOUNT
Company Credit Alerts
Recent Alerts
Credit Risk Increase
No
Overall Payments
No
Peer Payments
No
Bankruptcy
No
Tax Liens
No
UCC Filings
No
See All Credit Alerts On Your Customers From The Past 12 Months
Company News
Latest News
BRAINSTORM CELL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Thera
Business Wire Professional Services News
Dec 30 2023
BrainStorm Cell Therapeutics spikes on patent wins
Seeking Alpha Latest
Dec 26 2023
BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportu
Dec 20 2023
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Cla
Benzinga.com
Nov 17 2023
Analyze Your Entire AR Portfolio with One Free Credit Tool
LEARN MORECompany Buying Behavior
Overall Company Spend
Credit Analysis Tip
Purchases of key products and services provides insight into whether a business is growing or declining financially. Analyzing spending enables creditors predict risk scenarios before other credit analysis methods. Lean how in our latest case study.
DOWNLOAD CASE STUDYCompany Credit Alerts
Recent Alerts
Credit Risk Increase
No
Overall Payments
No
Peer Payments
No
Bankruptcy
No
Tax Liens
No
UCC Filings
No
See All Credit Alerts On Your Customers From The Past 12 Months
Sales Insights
More Businesses Like this
Discover other companies in the same industry you can sell to: